Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis

International Immunology

Volumn 12, Issue 12, 2000, Pages 1641-1650

  Tejada Simon, Maria V ^a   Zang, Ying C Q ^a   Yang, Deye ^a   Hong, Jian ^a   Li, Sufang ^a   Singh, Rana A K ^a   Van Den Berg Loonen, Ella ^b   Killian, James M ^a   Rivera, Victor M ^a   Zhang, Jingwu Z ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Multiple sclerosis; Myelin; T cells

Indexed keywords

AMINO ACID; CYTOKINE; EPITOPE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE; PROTEOLIPID PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REMISSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 0034526179     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.12.1641     Document Type: Article

References (53)

1. Defining the clinical course of multiple sclerosis: Results of an international survey
2. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
3. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Score (EDSS)
4. Autoreactive T cells in multiple sclerosis
5. Increased frequency of interleukin-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
6. T cell recognition of an immunodominant MBP epitope in multiple sclerosis
7. Myelin autoreactivity in multiple sclerosis: Recognition of MBP in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors
8. A MBP peptide is recognized by cytotoxic T cells in the context of hour HLA-DR types associated with multiple sclerosis
9. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls
10. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulation mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
11. Myelin oligodendrocyte glyco-protein: A novel candidate autoantigen in multiple sclerosis
12. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells
13. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
14. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: In vitro selection from unprimed rat T lymphocyte populations
15. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis
16. Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules
17. Myelin basic protein-reactive T cells in multiple sclerosis: Pathologic relevance and therapeutic targeting
18. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans
19. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides
20. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects
21. Multiple sclerosis T and B-cell responses to the extracellular domain of myelin oligodendrocyte glycoprotein
22. + multiple sclerosis
23. Direct ex vivo analysis of activated Fas-sensitive autoireactive T cells in human autoimmune disease
24. Selection for T cell receptor Vb-Db-Jb gene rearrangements with specificity for a MBP peptide in brain lesions of multiple sclerosis
25. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals
26. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity and cytotoxicity
27. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide
28. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: Restricted T cell receptor V gene rearrangements and CDR3 sequence
29. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: Structural requirements and clinical implications
30. A review of T-cell receptors in multiple sclerosis: Clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide
31. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls
32. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients
33. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis
34. T cells responsive to myelin basic protein in patients with multiple sclerosis
35. Large scale preparation of myelin basic protein of several mammalian species
36. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial
37. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
38. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis
39. MHC restricted clonotypic depletion of human myelin basic protein by T cell vaccination
40. Specificity of T lymphocyte lines for peptides of myelin basic protein
41. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
42. Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease
43. A cell culture model for T lymphocyte clonal anergy
44. Early signaling defects in humans T cells anergized by T cell presentation of autoantigen
45. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
46. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
47. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis
48. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
49. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
50. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system
51. Interferon beta induces T-helper 2 immune deviation in MS
52. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis